Key facts
- Liberation Bioindustries’s last known valuation is $178.0M (Dec 2025).
- It has raised $132.2M across 1 recorded rounds; the latest was Later Stage VC ($60.2M) in Nov 2025.
- Notable investors include Siddhi Capital, CPT Capital, Meach Cove Capital, Echo Investment Capital, Agronomics — 9 tracked in total.
- Liberation Bioindustries has filed 1 Form D with the SEC, most recently Dec 2025 ($60.2M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Liberation Bioindustries
Funding rounds
1 roundsAbout Liberation Bioindustries
Developer of an industrial biotechnology system designed to address the growing fermentation capacity gap in cellular agriculture. The company engages in infrastructure that commercializes novel protein manufacturing at the scale and cost structure required by the market, enabling biology innovators to achieve price parity with animal protein and customers to access healthy foods.
- Sector
- Business Products and Services (B2B)
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 19
- Website
- liberation.bio/
- Ownership
- Privately Held (backing)
Liberation Bioindustries doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Liberation Bioindustries shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Liberation Bioindustries in its N-PORT filings yet. We sweep new filings monthly.